NACDS president and CEO Steve Anderson noted that pharmacies have proven themselves again throughout the pandemic as the face of neighborhood health care every step of the way.
Pfizer’s Xeljanz is now approved for the treatment of adults with active ankylosing spondylitis who have had an inadequate response or intolerance to one or more tumor necrosis factor blockers.
The National Association of Chain Drug Stores, National Community Pharmacists Association and American Pharmacists Association commended the Biden administration for initiating action to rein in DIR fees.